Clinical Trial Update: Safety and Efficacy Study of Add On Aliskiren in Patients With Heart Failure and Renal Impairment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating add-on aliskiren in patients with heart failure and kidney failure has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Kidney Failure

Drugs mentioned

• Tekturna (aliskiren)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Heart Failure, Kidney Failure | Phase 2 | Status: TERMINATED